C
Centrum Medyczne KERmed | Dermatology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Lorcaserin HCl
BELVIQ
Apixaban
Vancomycin
Etripamil
OP1
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 6 total trials
A Phase 1b study to evaluate the safety and tolerability of MB310 given to patients who have active mild-to-moderate ulcerative colitis.
Active, not recruiting
Ulcerative Colitis
Biological: MB310
Drug: Vancomycin
Rationale: Allergic rhinitis/rhinoconjunctivitis (ARC) is a global health problem, affecting 10-25% of the population. Allergen-specific immunotherap...
Active, not recruiting
House Dust Mite Rhinitis
House Dust Mite Allergy
Biological: PURETHAL Mites 50,000 AUeq/ml
Biological: Biological/Vaccine: Placebo
Trial sponsors
A
H
M
M
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems